Schiffmann Raphael

Raphael Schiffmann has a diverse work experience in the medical field. Schiffmann currently holds the position of SVP and Therapeutic Area Head for LSD and Neuromuscular Diseases at 4D Molecular Therapeutics since September 2020. Prior to this, they worked for Baylor Scott & White Health where they served as the Principal Investigator and Neurologist from January 2008 to June 2020. Additionally, during their time at Baylor Scott & White, they held the role of Director at the Institute of Metabolic Disease from January 2008 to June 2019.

Schiffmann Raphael obtained a Master of Health Sciences degree in Clinical Research from Duke University, where they studied from 1998 to 2000. Prior to that, they attended the University of Liège from 1973 to 1980, where they also completed a degree in Medicine.